Ladenburg Thalmann Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $2.16M | Buy |
10,283
+1,513
| +17% | +$317K | 0.01% | 836 |
|
2019
Q3 | $1.48M | Buy |
8,770
+3,683
| +72% | +$623K | 0.01% | 979 |
|
2019
Q2 | $932K | Sell |
5,087
-1,081
| -18% | -$198K | 0.01% | 1278 |
|
2019
Q1 | $1.14M | Sell |
6,168
-2,626
| -30% | -$484K | 0.01% | 1099 |
|
2018
Q4 | $1.47M | Buy |
8,794
+3,553
| +68% | +$595K | 0.01% | 821 |
|
2018
Q3 | $1.01M | Buy |
5,241
+516
| +11% | +$99.5K | 0.01% | 1113 |
|
2018
Q2 | $771K | Hold |
4,725
| – | – | 0.01% | 1227 |
|
2018
Q1 | $771K | Buy |
4,725
+247
| +6% | +$40.3K | 0.01% | 1227 |
|
2017
Q4 | $671K | Sell |
4,478
-1,977
| -31% | -$296K | 0.01% | 1326 |
|
2017
Q3 | $983K | Buy |
6,455
+1,876
| +41% | +$286K | 0.01% | 1007 |
|
2017
Q2 | $590K | Buy |
4,579
+1,716
| +60% | +$221K | 0.01% | 1279 |
|
2017
Q1 | $312K | Buy |
2,863
+405
| +16% | +$44.1K | ﹤0.01% | 1615 |
|
2016
Q4 | $184K | Sell |
2,458
-89
| -3% | -$6.66K | ﹤0.01% | 1877 |
|
2016
Q3 | $222K | Sell |
2,547
-35
| -1% | -$3.05K | ﹤0.01% | 1691 |
|
2016
Q2 | $221K | Sell |
2,582
-18
| -0.7% | -$1.54K | ﹤0.01% | 1619 |
|
2016
Q1 | $206K | Sell |
2,600
-1,684
| -39% | -$133K | ﹤0.01% | 1589 |
|
2015
Q4 | $538K | Buy |
4,284
+1,527
| +55% | +$192K | 0.01% | 985 |
|
2015
Q3 | $289K | Buy |
2,757
+694
| +34% | +$72.7K | 0.01% | 1241 |
|
2015
Q2 | $257K | Buy |
2,063
+415
| +25% | +$51.7K | ﹤0.01% | 1427 |
|
2015
Q1 | $195K | Sell |
1,648
-34
| -2% | -$4.02K | ﹤0.01% | 1593 |
|
2014
Q4 | $196K | Buy |
1,682
+100
| +6% | +$11.7K | ﹤0.01% | 1437 |
|
2014
Q3 | $173K | Buy |
1,582
+51
| +3% | +$5.58K | ﹤0.01% | 1290 |
|
2014
Q2 | $140K | Sell |
1,531
-514
| -25% | -$47K | ﹤0.01% | 1400 |
|
2014
Q1 | $147K | Buy |
2,045
+170
| +9% | +$12.2K | ﹤0.01% | 1296 |
|
2013
Q4 | $140K | Sell |
1,875
-352
| -16% | -$26.3K | ﹤0.01% | 1261 |
|
2013
Q3 | $163K | Buy |
2,227
+50
| +2% | +$3.66K | 0.01% | 1104 |
|
2013
Q2 | $177K | Buy |
+2,177
| New | +$177K | 0.01% | 1035 |
|